Founder of Surrozen, Inc., Roeland Nusse is on the board of Bio-Techne Corp. and Professor at Stanford University.
In the past Dr. Nusse held the position of Member of The Royal Netherlands Academy of Arts & Sciences, Member of European Molecular Biology Organization, Head-Molecular Biology & Staff Scientist at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh and Member of American Academy of Arts & Sciences.
Dr. Nusse received an undergraduate degree from the University of Amsterdam and a doctorate from Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh.
|02/08/2021||6,000||Disposition at $385.08 per share.||2,310,480|
|02/08/2021||5,000||Derivative/Non-derivative trans. at $66.9 per share.||334,500|
|02/08/2021||1,000||Derivative/Non-derivative trans. at $70.35 per share.||70,350|
|10/29/2020||391||Award at $0 per share.||0|
|11/25/2019||8,347||Disposition at $219.33 per share.||1,830,748|
|11/25/2019||5,000||Derivative/Non-derivative trans. at $61.46 per share.||307,300|
|11/25/2019||10,000||Derivative/Non-derivative trans. at $60.46 per share.||604,600|
|10/24/2019||495||Award at $0 per share.||0|
|10/25/2018||514||Award at $0 per share.||0|
|10/26/2017||739||Award at $0 per share.||0|
|10/27/2016||914||Award at $0 per share.||0|